Concepedia

Sven Schnaidt

SS

23

Publications

7.7K

Citations

17

H-Index

2013

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Heidelberg University

Boehringer Ingelheim (Norway)

Monash University

University Hospital Heidelberg

Sven Schnaidt is an author at Boehringer Ingelheim (Germany) specializing in medicine, chronic kidney disease, and pathology.

Top concepts

Publications per year

2013–2024

23

Publications

23

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · New England Journal of Medicine · 2021 · 4.3K citations · Full text

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen et al. · JAMA · 2018 · 1K citations · Full text

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Milton Packer, Stefan D. Anker, Javed Butler et al. · Circulation · 2020 · 408 citations · Full text

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status

Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · Circulation · 2020 · 332 citations · Full text

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Milton Packer, Javed Butler, Faı̈ez Zannad et al. · Circulation · 2021 · 332 citations · Full text

Rows per page

1–5 of 23